Evidence map›Paper›PMID 37329881›Full record

ArticleCell host & microbe2023

Virion glycosylation influences mycobacteriophage immune recognition.

Krista G Freeman, Anna C Robotham, Olivia B Parks, Lawrence Abad, Deborah Jacobs-Sera, Michael J Lauer, Jennifer M Podgorski, Yu Zhang, John V Williams, Simon J White and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Cell host & microbe, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. All the world's a phage.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. ICTV Virus Taxonomy Profile:The Journal of general virology · 2025
    Review
  15. Article
  16. A dinoflagellate-infecting giant virus with a micron-length tail.bioRxiv : the preprint server for biology · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Krista G FreemanDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Anna C RobothamHuman Health Therapeutics, National Research Council of Canada, 100 Sussex Drive, Ottawa, ON K1A 0R6, Canada.
Olivia B ParksUPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15260, USA; Department of Pediatrics and Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA.
Lawrence AbadDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Deborah Jacobs-SeraDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Michael J LauerDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Jennifer M PodgorskiBiology/Physics Building, Department of Molecular and Cell Biology, University of Connecticut, Storrs, CT 06269-3125, USA.
Yu ZhangUPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15260, USA; Department of Pediatrics and Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA.
John V WilliamsUPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15260, USA; Department of Pediatrics and Center for Vaccine Research, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA.
Simon J WhiteBiology/Physics Building, Department of Molecular and Cell Biology, University of Connecticut, Storrs, CT 06269-3125, USA.
John F KellyHuman Health Therapeutics, National Research Council of Canada, 100 Sussex Drive, Ottawa, ON K1A 0R6, Canada.
Graham F HatfullDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA. Electronic address: gfh@pitt.edu.
Welkin H PopeScience Department, Chatham University, Pittsburgh, PA 15232, USA.
University of Pittsburgh · USNational Research Council Canada · CAUniversity of Connecticut · USChatham University · USChildren's Hospital of Pittsburgh · US

Funding

Pacific Northwest Center for Cryo-EM - Screening supplementU24GM129547 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI EVANS, JAMES E, GOUAUX, JAMES E · 2018 to 2023
$54.8M
TRAINING PROGRAM FOR MD/PHD STUDENTST32GM008208 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STEINMAN, RICHARD A · 1987 to 2021
$15.4M
Autoimmunity and Immunopathology Training ProgramT32AI089443 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHLOMCHIK, MARK J · 2010 to 2024
$6.6M
Host Determinants of Human Metapneumovirus Immunity and PathogenesisR01AI085062 · NIAID · VANDERBILT UNIVERSITY · PI John V. Williams · 2010 to 2026
$5.6M
Bacteriophage diversity, dynamics, function, and exploitationR35GM131729 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Graham F. Hatfull · 2019 to 2026
$3.6M
Improving phage-based medicine with immunoengineeringK99AI173544 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FREEMAN, KRISTA GABRIELLE · 2023 to 2024
$200k
NIAID NIH HHS K99 AI173544NIAID NIH HHS R01 AI085062NIAID NIH HHS T32 AI089443NIGMS NIH HHS R35 GM131729NIGMS NIH HHS T32 GM008208NIGMS NIH HHS U24 GM129547
6 · The paper itself

Abstract

Glycosylation of eukaryotic virus particles is common and influences their uptake, trafficking, and immune recognition. In contrast, glycosylation of bacteriophage particles has not been reported; phage virions typically do not enter the cytoplasm upon infection, and they do not generally inhabit eukaryotic systems. We show here that several genomically distinct phages of Mycobacteria are modified with glycans attached to the C terminus of capsid and tail tube protein subunits. These O-linked glycans influence antibody production and recognition, shielding viral particles from antibody binding and reducing production of neutralizing antibodies. Glycosylation is mediated by phage-encoded glycosyltransferases, and genomic analysis suggests that they are relatively common among mycobacteriophages. Putative glycosyltransferases are also encoded by some Gordonia and Streptomyces phages, but there is little evidence of glycosylation among the broader phage population. The immune response to glycosylated phage virions in mice suggests that glycosylation may be an advantageous property for phage therapy of Mycobacterium infections.

Indexed as

BacteriophagesMycobacteriophagesAnimalsGlycosylationGlycosyltransferasesMicePolysaccharidesVirionGlycosyltransferasesPolysaccharidesbacteriophagesphage therapyviral glycosylation

Identifiers

PMID37329881
PMCPMC10527164
OpenAlexW4380987160

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.